NextCell Pharma AB
STO:NXTCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NextCell Pharma AB
STO:NXTCL
|
SE |
|
NTG Nordic Transport Group AS
CSE:NTG
|
DK |
|
Kimberly-Clark de Mexico SAB de CV
F:4FX
|
MX |
|
Siemens Healthineers AG
XETRA:SHL
|
DE |
|
Tokyo Century Corp
F:59O
|
JP |
|
C
|
Cloudflare Inc
XMUN:8CF
|
US |
|
D
|
Datatec Ltd
JSE:DTC
|
ZA |
|
D
|
DICK'S Sporting Goods Inc
F:DSG
|
US |
|
M
|
Main Street Capital Corp
F:13M
|
US |
|
S
|
Sanrio Co Ltd
XMUN:SJ8
|
JP |
|
C
|
Chemours Co
SWB:2CU
|
US |
|
M
|
Molson Coors Canada Inc
F:65K
|
CA |
|
FibroGen Inc
F:1FG0
|
US |
|
Prodia Widyahusada Tbk PT
IDX:PRDA
|
ID |
|
A
|
Aya Gold & Silver Inc
XBER:0HE1
|
CA |
|
Sekisui Chemical Co Ltd
TSE:4204
|
JP |
|
Delek Logistics Partners LP
NYSE:DKL
|
US |
|
Burckhardt Compression Holding AG
F:B5H
|
CH |
Wall St Price Targets
NXTCL Price Targets Summary
NextCell Pharma AB
According to Wall Street analysts, the average 1-year price target for NXTCL is 3.57 SEK with a low forecast of 3.54 SEK and a high forecast of 3.68 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NXTCL's stock price target?
Price Target
3.57
SEK
According to Wall Street analysts, the average 1-year price target for NXTCL is 3.57 SEK with a low forecast of 3.54 SEK and a high forecast of 3.68 SEK.